prnewswire.comGlycoNex Announces Publication of Preclinical Study on GNX1021, a Novel Glycan-Targeted ADC for Gastric Cancer12 days ago
prnewswire.comADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 202812 days ago
prnewswire.comAgree Realty Announces Pricing of $400 Million of 5.600% Senior Unsecured Notes Due 2035about 1 month ago
prnewswire.comMinghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater Chinaabout 2 months ago
prnewswire.comBioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidateabout 2 months ago
CashuAgree Realty's ADC Therapeutics Implements Strategic Overhaul with $100 Million Financing Plan10 days ago